| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |